- Report
- January 2025
- 690 Pages
Global
From €4282EUR$4,799USD£3,776GBP
- Report
- September 2025
- 452 Pages
Global
From €4417EUR$4,950USD£3,895GBP
- Report
- October 2025
- 189 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- November 2025
- 193 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- April 2025
- 175 Pages
Global
From €4006EUR$4,490USD£3,533GBP
- Report
- November 2025
- 177 Pages
Global
From €5220EUR$5,850USD£4,603GBP
- Report
- September 2025
- 141 Pages
Global
From €2275EUR$2,549USD£2,006GBP
€2676EUR$2,999USD£2,360GBP
- Report
- November 2024
- 150 Pages
Global
From €3435EUR$3,850USD£3,029GBP
€4328EUR$4,850USD£3,816GBP
- Report
- April 2025
- 93 Pages
Global
From €3500EUR$4,202USD£3,194GBP
- Report
- November 2024
- 219 Pages
Global
From €4457EUR$4,995USD£3,930GBP
- Report
- July 2025
- 194 Pages
Global
From €4015EUR$4,500USD£3,540GBP
- Report
- July 2025
- 170 Pages
Global
From €3678EUR$4,123USD£3,243GBP
€4328EUR$4,850USD£3,816GBP
- Report
- January 2025
- 867 Pages
Global
From €4282EUR$4,799USD£3,776GBP
- Report
- May 2025
- 967 Pages
Global
From €7272EUR$8,150USD£6,412GBP
- Report
- November 2024
- 120 Pages
Global
From €5309EUR$5,950USD£4,681GBP
- Report
- October 2025
- 198 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 198 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 184 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 180 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP
- Report
- October 2025
- 183 Pages
Global
From €3163EUR$3,545USD£2,789GBP
€3515EUR$3,939USD£3,099GBP

The Wearable Injector market is a subset of the Infusions and Injectables market, which includes a variety of medical devices used to deliver drugs, fluids, and other substances directly into a patient's body. Wearable Injectors are a type of infusion device that are designed to be worn on the body, allowing for continuous or periodic drug delivery. These devices are typically used to deliver medications such as insulin, hormones, and antibiotics, and can be used to treat a variety of conditions. Wearable Injectors offer a number of advantages over traditional infusion methods, including improved patient compliance, increased accuracy of drug delivery, and improved safety.
Some of the major players in the Wearable Injector market include Insulet Corporation, Valeritas, Inc., Becton Dickinson and Company, Tandem Diabetes Care, Inc., and Ypsomed AG. Show Less Read more